Back
EHRA Premium Access

The phospholamban (PLN) p.Arg14del risk model; Longitudinal validation and reevaluation of predictors regarding sudden cardiac death (SCD)

Session: ePoster session 2
Topic: Device Treatment
Speaker: Miss M. Van Der Heide (Amsterdam, NL)
Event: EHRA 2023

Congress Presentation

About the speaker

Miss Myrthe Van Der Heide

Amsterdam University Medical Centre, Amsterdam (Netherlands (The))
0 follower

9 more presentations in this session

Weight-loss management after catheter ablation of atrial fibrillation

Speaker: Miss A. Burbelka (Rzeszow, PL)

Access
Abstract
Slides
Thumbnail

Cardiac hereditary diseases: genetic insights from a single center 15-year experience

Speaker: Doctor A. Porretta (Lausanne, CH)

Access
Abstract
Slides
Thumbnail

The safety and efficacy of rotor ablation in right atrium after pulmonary vein isolation in patients with persistent atrial fibrillation

Speaker: Doctor A. Yoshida (Ono, JP)

Access
Abstract
Slides
Thumbnail

Pitfalls and limitations in the assessment of the HV interval in a transcatheter aortic valve replacement population. A prospective analysis.

Speaker: Doctor C. Teres (Lausanne, CH)

Access
Abstract
Slides
Thumbnail

Lesion formation in irrigated RF-ablation is not linear, but monoexponential

Speaker: Doctor F. Bahlke (Munich, DE)

Access
Abstract
Slides
Thumbnail

Access the full session

ePoster session 2

Speakers: Miss M. Van Der Heide, Miss A. Burbelka, Doctor A. Porretta, Doctor A. Yoshida, Doctor C. Teres...
Access
Thumbnail

About the event

Image

EHRA 2023

16 April - 18 April 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb